BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33190969)

  • 1. Differential Immune Modulation With Carbon-Ion Versus Photon Therapy.
    Spina CS; Tsuruoka C; Mao W; Sunaoshi MM; Chaimowitz M; Shang Y; Welch D; Wang YF; Venturini N; Kakinuma S; Drake CG
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):813-818. PubMed ID: 33190969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells.
    Manukian G; Kivolowitz C; DeAngelis T; Shastri AA; Savage JE; Camphausen K; Rodeck U; Zarif JC; Simone NL
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1341-1349. PubMed ID: 33647370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy.
    Bos PD; Plitas G; Rudra D; Lee SY; Rudensky AY
    J Exp Med; 2013 Oct; 210(11):2435-66. PubMed ID: 24127486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
    Young MR; McCloskey G; Wright MA; Pak AS
    Cancer Immunol Immunother; 1994 Jan; 38(1):9-15. PubMed ID: 8299123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer.
    Hu W; Pei Y; Ning R; Li P; Zhang Z; Hong Z; Bao C; Guo X; Sun Y; Zhang Q
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4533-4545. PubMed ID: 36138265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of low dose heavy ion irradiation on subset percentage and cytokines expression of peripheral blood lymphocytes in patients with pancreatic cancer].
    Chen Y; Wang C; He M; Zhang H; Chen X
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):435-9. PubMed ID: 25241785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time post-lung transplant correlates with increasing peripheral blood T cell granzyme B and proinflammatory cytokines.
    Hodge G; Hodge S; Li-Liew C; Chambers D; Hopkins P; Reynolds PN; Holmes M
    Clin Exp Immunol; 2010 Sep; 161(3):584-90. PubMed ID: 20528884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors.
    Tähtinen S; Kaikkonen S; Merisalo-Soikkeli M; Grönberg-Vähä-Koskela S; Kanerva A; Parviainen S; Vähä-Koskela M; Hemminki A
    PLoS One; 2015; 10(6):e0131242. PubMed ID: 26107883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer.
    Reers S; Pfannerstill AC; Rades D; Maushagen R; Andratschke M; Pries R; Wollenberg B
    Anticancer Res; 2013 Jun; 33(6):2481-9. PubMed ID: 23749899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between IFNAR1 expression in peripheral blood T lymphocytes and inflammatory cytokines, tumor-infiltrating lymphocytes, and chemosensitivity in patients with colorectal cancer.
    Yang L; Zhang X; Huang X; Dong X; Jing S; Zhang Y; Zhao B; Wang Z; Qu H
    Cytokine; 2022 Nov; 159():156008. PubMed ID: 36063748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells.
    Prasse A; Georges CG; Biller H; Hamm H; Matthys H; Luttmann W; Virchow JC
    Clin Exp Immunol; 2000 Nov; 122(2):241-8. PubMed ID: 11091281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.
    Ali R; Naqvi RA; Kumar S; Bhat AA; Rao DN
    Scand J Immunol; 2013 May; 77(5):361-71. PubMed ID: 23480362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist.
    Knudson KM; Hicks KC; Ozawa Y; Schlom J; Gameiro SR
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway.
    Guo Y; Shen R; Wang F; Wang Y; Xia P; Wu R; Liu X; Ye W; Tian Y; Wang D
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6315-6328. PubMed ID: 36745223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.
    Kaplanov I; Carmi Y; Kornetsky R; Shemesh A; Shurin GV; Shurin MR; Dinarello CA; Voronov E; Apte RN
    Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1361-1369. PubMed ID: 30545915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.